When can the faith and patience of QT Vascular shareholders be repaid?

SINGAPORE (June 29): QT Vascular specialises in the development of medical devices for treating vascular diseases, specifically catheters inserted into the body to clear blocked arteries. It has developed six products so far.

In May alone, QT Vascular inked deals worth more than $98.4 million to sell the licences and rights to its coronary products to multinational medical companies. A bonanza for shareholders, however, is not quite in sight.

In fact, QT Vascular has yet to distribute a dividend since its IPO on the Catalist in 2014. And, shares in the company have been trading comparatively poorly; the stock has a negative return of 96.2% over the last four years.

---

Related Stories

• Quantum Healthcare to raise $1 million via placement of new shares
• QT Vascular shareholders vote against new board candidates; company to repay US$1 mil debt by issuing new shares
• QT Vascular board faces ouster, CEO quits

---